Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ) has shared an announcement.
Venus Medtech (Hangzhou) Inc. has announced the resignation of company secretary and authorized representative Mr. Wong Wai Chiu, effective 6 May 2026, with the board noting there is no disagreement or outstanding matter related to his departure that would concern shareholders or the exchange. The company has appointed Ms. Yip Chui Mei, an experienced corporate governance professional from SWCS Corporate Services Group with over a decade in company secretarial work and relevant professional qualifications, as the new company secretary and authorized representative, underscoring an orderly transition in its compliance and governance functions.
The board expressed its appreciation to Mr. Wong for his contributions and formally welcomed Ms. Yip to her new roles, signaling continuity in regulatory liaison and corporate administration for investors and other stakeholders. The announcement also reaffirmed the current composition of the board, including executive, non-executive and independent non-executive directors, highlighting the company’s maintained governance structure amid this key management change.
More about Venus Medtech (Hangzhou), Inc. Class H
Venus Medtech (Hangzhou) Inc. is a Chinese medical technology company listed in Hong Kong that focuses on developing and commercializing cardiovascular devices and related medtech solutions. The company targets both domestic and international markets, leveraging regulatory access to the Hong Kong capital market to support its growth and corporate governance framework.
Average Trading Volume: 1,139,237
Technical Sentiment Signal: Sell
Current Market Cap: HK$793.8M
Find detailed analytics on 2500 stock on TipRanks’ Stock Analysis page.